Reimbursement

Results: 1 - 4 of 4
view
To what extent can the European Society for Blood and Marrow Transplantation (EBMT) registry enable outcomes-based reimbursement in oncology in the UK?

In previous work, we have shown that outcomes-based reimbursement (OBR), whereby payments to...

Read more
view
To what extent can the Systemic Anti-Cancer Therapy (SACT) database enable outcomes-based reimbursement in oncology in England?

In previous work, we have shown that outcomes-based reimbursement (OBR), whereby payments to...

Read more
view
Can the existing data collection infrastructures for patient outcomes enable outcomes-based reimbursement in the UK?

Outcomes-based reimbursement, whereby the financial remuneration for a therapy is made...

Read more
view
Reimbursement of macrophage therapy liver cirrhosis treatment

Cell and Gene Therapy Catapult built a health economics model to detail the reimbursement...

Read more

Discover who we are

 
Sign up